Format

Send to

Choose Destination
Leukemia. 2017 Dec;31(12):2844-2847. doi: 10.1038/leu.2017.264. Epub 2017 Aug 18.

Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib.

Author information

1
Department of Hematology, Nanfang Hospital, Southern Medical University, GuangZhou, China.
2
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
3
ARUP Laboratories, Salt Lake City, UT, USA.
4
Service d'Hématologie Adulte and INSERM UMR1160, Hospital Saint-Louis, Paris, France.
5
Laboratory of Hematology, University Hospital Saint- Louis and EA3518, University Paris Diderot, Paris.
6
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
7
Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.
PMID:
28819281
DOI:
10.1038/leu.2017.264
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center